EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center

Barut Dogan iD, Yildirim Arslan Sema iD, Kunay Bora iD, Umman Veysel iD, Dernek Benan, Kıran Taşçı Ezgi iD, Akkus Kayali Gozde iD, Derya Demir iD, Nazan Ozsan iD, Mine Hekimgil iD, Sahbudak Bal Zumrut iD, Karakoyun Miray iD und 2 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Barut Dogan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition Disease, Department of Pediatrics, Medical School of Ege University, İzmir, Türkiye. Hauptthemen laut MEDLINE: Lymphoproliferative Disorders, Liver Transplantation, Epstein-Barr Virus Infections, DNA, Viral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most prevalent malignancy that complicates both adult and pediatric solid organ transplantation is post‐transplant lymphoproliferative disorder (PTLD). This study aimed to analyze the clinical and pathological characteristics, treatments, and outcomes of Epstein‐Barr virus (EBV) DNAemia and PTLD in pediatric liver transplant recipients. A retrospective chart review was performed on 112 patients less than 18 years of age who underwent isolated orthotopic liver transplantation (OLT) between 2010 and 2022 at Ege University Children's Hospital. Data gathered for 1‐year post‐OLT included age at OLT, EBV, immunoglobulin (Ig)M/IgG status of the donor and recipient, indication for OLT, induction regimen, all immunosuppression levels, date and result of EBV polymerase chain reaction testing, rejection episodes documented by liver biopsy, and the development of PTLD. Forty‐nine patients (43.75%) developed EBV DNAemia (median interval from surgery: 2 months, min–max: 2–36), of which 43 (87.8%) grafts came from living donors, and 6 (12.2%) came from deceased donors. Nine (18.4%) patients died during follow‐up, and eight (16.3%) developed PTLD. Of these 8 patients; five patients developed EBV‐related disease, one child developed hemophagocytic lymphohistiocytosis, one developed aplastic anemia, and one child developed B cell lymphoma. When PTLD patients and without‐PTLD patients were compared, pediatric intensive care unit hospitalization, abnormal bone marrow biopsy findings, lymphadenopathy, age at diagnosis of EBV DNAemia, EBV viral load, tacrolimus (FK 506) pre‐infection, were higher and tacrolimus 1‐month levels were lower in patients with PTLD ( p < 0.05). In logistic regression analysis, we showed that the age at diagnosis of EBV DNAemia was significantly higher in children with PTLD ( p = 0.045; OR: 1.389; 95% CI: 1.007–1.914). PTLD is a rare but severe complication associated with EBV after OLT. This study demonstrated that PTLD is associated with older age, higher tacrolimus blood levels before EBV DNAemia, and higher peak EBV viral load at 1 month of EBV DNAemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoproliferative DisordersLiver TransplantationEpstein-Barr Virus InfectionsDNA, ViralHerpesvirus 4, HumanHumansRetrospective StudiesChildChild, PreschoolMaleFemaleInfantAdolescent

Stichwörter der Autor:innen

Epstein‐Barr viruspediatric liver transplantationpost‐transplant lymphoproliferative disorder

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition Disease, Department of Pediatrics, Medical School of Ege University, İzmir, Türkiye.
  • Division of Infectious Disease, Department of Pediatrics, Medical School of Ege University, Izmir, Turkey.
  • Department of General Surgery, Medical School of Ege University, İzmir, Turkey.
  • Department of Pediatrics, Medical School of Ege University, Izmir, Turkey.
  • Department of Pediatrics, Sivas Numune Hospital, Gastroenterology, Hepatology, and Nutrition Disease, Sivas, Turkey.
  • Department of Microbiology, Medical School of Ege University, Izmir, Turkey.

ORCID-Profile: Barut Dogan, Yildirim Arslan Sema, Kunay Bora, Umman Veysel, Kıran Taşçı Ezgi, Akkus Kayali Gozde, Derya Demir, Nazan Ozsan, Mine Hekimgil, Sahbudak Bal Zumrut, Karakoyun Miray, Cetin Funda, Aydogdu Sema

Zitieren

APA

Dogan, B., Sema, Y. A., Bora, K., Veysel, U., Benan, D., Ezgi, K. T., Gozde, A. K., Demir, D., Ozsan, N., Hekimgil, M., Zumrut, S. B., Miray, K., Funda, C., & Sema, A. (2024). Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center. Journal of Medical Virology. https://doi.org/10.1002/jmv.29767

Vancouver

Dogan B, Sema YA, Bora K, Veysel U, Benan D, Ezgi KT, et al. Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center. Journal of Medical Virology. 2024. doi:10.1002/jmv.29767

BibTeX
@article{Dogan2024,
  author = {Dogan, Barut and Sema, Yildirim Arslan and Bora, Kunay and Veysel, Umman and Benan, Dernek and Ezgi, Kıran Taşçı and Gozde, Akkus Kayali and Demir, Derya and Ozsan, Nazan and Hekimgil, Mine and Zumrut, Sahbudak Bal and Miray, Karakoyun and Funda, Cetin and Sema, Aydogdu},
  title = {Post‐transplant lymphoproliferative disorder associated Epstein‐Barr virus DNAemia after liver transplantation in children: Experience from single center},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29767}
}
Kostenlos starten →